Bank Of New York Mellon Corp Clear Point Neuro, Inc. Transaction History

Bank Of New York Mellon Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$7.33 - $10.63 $78,152 - $113,337	10,662 New	10,662 $90 Million
Q4 2022 Feb 14, 2023	BUY	$7.7 - $11.21 $82,097 - $119,521	10,662 New	10,662 $90,000
Q3 2022 Nov 14, 2022	BUY	$9.82 - $16.49 $104,799 - $175,981	10,672 New	10,672 $110,000
Q2 2022 Aug 15, 2022	SELL	$7.09 - $13.65 $361,547 - $696,068	-50,994 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$7.8 - $11.6 $4,329 - $6,438	555 Added 1.1%	50,994 $531,000
Q4 2021 Feb 11, 2022	BUY	$11.08 - $18.86 $2,925 - $4,979	264 Added 0.53%	50,439 $566,000
Q3 2021 Nov 12, 2021	BUY	$16.58 - $22.25 $111,666 - $149,853	6,735 Added 15.5%	50,175 $891,000
Q2 2021 Aug 11, 2021	BUY	$17.23 - $22.77 $571,777 - $755,622	33,185 Added 323.6%	43,440 $829,000
Q4 2020 Feb 09, 2021	BUY	$5.11 - $15.89 $52,403 - $162,951	10,255 New	10,255 $162,000

6.83M

84.3K

56.7K

Ticker CLPT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 24,488,300
Market Cap $439M
Description
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.